Showing results (31-40 of 153) with videos related to
Sort By:
Pageof 16
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1984
Target cell susceptibility to immune lysis and expression of MHC antigens are independent of position in the cell cycleD T Harris, R P SekalyMedical and Pediatric Oncology|January 1, 1978
Phase II study of subcutaneously administered 5-azacytidine (NSC-102816) in patients with metastatic malignant melanomaR E Bellet, R B Catalano, M J Mastrangelo, et al.International Journal of Cancer|February 20, 1992
Effective combination chemo/hormonal therapy for malignant melanoma: experience with three consecutive trialsE F McClay, M J Mastrangelo, D Berd, et al.Seminars in Oncology|February 1, 1996
Gene therapy for human cancer: an essay for cliniciansM J Mastrangelo, D Berd, F E Nathan, et al.Cancer Treatment Reports|December 1, 1978
Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosoureaR E Bellet, R B Catalano, M J Mastrangelo, et al.Cancer Treatment Reports|May 1, 1987
Combination chemotherapy and hormonal therapy in the treatment of malignant melanomaE F McClay, M J Mastrangelo, R E Bellet, et al.Cancer|October 11, 1975
Regression of pulmonary metastatic disease associated with intralesional BCG therapy of intracutaneous melanoma metastasesM J Mastrangelo, R E Bellet, J Berkelhammer, et al.Experimental Cell Research|May 1, 1985
Proliferative quiescence of normal mast cells resembles that of cold-sensitive mutant mastocytoma cells. Dominant expression of the quiescent state in heterokaryonsH Laeng, D T Harris, R SchindlerInternational Journal of Cancer|December 18, 2001
Treatment of metastatic melanoma with autologous, hapten-modified melanoma vaccine: regression of pulmonary metastasesD Berd, T Sato, H Cohn, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|July 1, 1980
Diffuse primary malignant melanoma after prior primary cutaneous malignant melanomaJ J Augsburger, J A Shields, M J Mastrangelo, et al.Pageof 16